Primaquine, the only widely available treatment to prevent relapsing Plasmodium vivax malaria, is produced as 15 mg tablets, and new paediatric formulations are being developed. To inform the optimal primaquine dosing regimen for children, we aimed to determine the efficacy and safety of different primaquine dose strategies in children younger than 15 years.

中文翻译：

---

伯氨喹治疗 15 岁以下儿童无并发症的间日疟原虫疟疾：系统评价和个体患者数据荟萃分析


伯氨喹是唯一一种广泛可用的预防间日疟原虫疟疾复发的治疗方法，生产为 15 毫克片剂，并且正在开发新的儿科制剂。为了告知儿童的最佳伯氨喹给药方案，我们旨在确定不同伯氨喹剂量策略对 15 岁以下儿童的有效性和安全性。